UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): May
31, 2007
NovaMed,
Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
0-26625
|
36-4116193
|
(State
or Other Jurisdiction of
Incorporation)
|
(Commission File
Number)
|
(IRS
Employer Identification
No.)
|
980
North Michigan Avenue, Suite 1620,
Chicago, Illinois
|
60611
|
(Address
of Principal Executive
Offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (312)
664-4100
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section
1 - Registrant’s Business and Operations
Item
1.01 - Entry into a Material Definitive Agreement
On
May
31, 2007, NovaMed, Inc. entered into a First Amendment to Credit Agreement
and
Consent to Acquisition (the “First Amendment”) with National
City Bank, as agent and lender, LaSalle Bank National Association, as
documentation agent and lender, and Associated Bank, N.A., Charter One Bank,
BMO
Capital Markets Financing, Inc., The Northern Trust Company and JPMorgan Chase
Bank, National Association as the other participating lenders. The First
Amendment amended the terms of the Sixth Amended and Restated Credit Agreement
dated as of February 7, 2007 (the “Credit Facility”) among the same parties.
Under the terms of the Credit Facility, we are required to obtain the consent
of
our lenders for any acquisition exceeding $20,000,000 individually. As described
in more detail in Section 2 below, on June 1, 2007, one of our wholly owned
subsidiaries, NovaMed Acquisition Company, Inc., acquired a
sixty-two and one-half percent (62.5%) equity interest in Surgery Center of
Kalamazoo, LLC, for a purchase price of $24,600,000, payable in cash at closing.
The First Amendment sets forth our lenders’ consent to this transaction as well
as modifications to various definitions and financial covenants to enable
Surgery Center of Kalamazoo, LLC, as a new subsidiary of NovaMed, Inc., to
continue to maintain its existing bank debt of approximately $1,830,000 with
a
commercial lending institution outside of the Credit Facility.
The
foregoing summary does not purport to be complete and is qualified in its
entirety by reference to the full text of the First Amendment, which is filed
herewith as Exhibit 10.55 and is incorporated herein by reference.
Section
2 - Financial Information
Item
2.01 Completion of Acquisition or Disposition of Assets
On
June
1, 2007, one of our wholly owned subsidiaries, NovaMed Acquisition Company,
Inc., acquired a sixty-two and one-half percent (62.5%) equity interest in
Surgery Center of Kalamazoo, LLC, the owner and operator of a multi-specialty
ambulatory surgery center (“ASC”) located in Portage, Michigan. In exchange for
this equity interest, NovaMed Acquisition Company, Inc. paid in cash at closing
the existing members of Surgery Center of Kalamazoo, LLC an aggregate purchase
price of $24,600,000. The individual physician-members of Surgery Center of
Kalamazoo, LLC collectively retained a thirty-seven and one-half percent (37.5%)
equity interest in the entity. Surgery Center of Kalamazoo, LLC’s assets include
equipment, furniture, business and medical records, licenses, permits, accounts
receivable, inventory and goodwill. These assets were historically used to
operate, and we intend to continue to use them to operate, an outpatient
surgical facility. The purchase price was negotiated and agreed upon through
arm’s length negotiations between the parties. NovaMed, Inc. funded the purchase
price through its existing cash as well as funds borrowed under its credit
facility with National City Bank, as agent for the various lenders
thereunder.
The
foregoing summary does not purport to be complete and is qualified in its
entirety by reference to the full text of the Purchase Agreement relating to
the
acquisition, which is filed herewith as Exhibit 2.1 and is incorporated herein
by reference.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits
(a) Financial
statements of businesses acquired
(b) Pro
forma
financial information
Financial
statements and pro forma financial information required by Items 9(a) and (b)
of
Form 8-K in connection with the matters reported in Item 2.01 above are
omitted pursuant to Items 9(a)(4) and 9(b)(2) of Form 8-K. We intend to
file such financial statements and pro forma financial information by amendment
to this Current Report within 71 days after the date this Current Report was
required to be filed.
(d) Exhibits
Exhibit Number |
|
Title |
|
|
|
2.1 |
|
Purchase Agreement dated as of June
1, 2007,
by and among NovaMed Acquisition Company, Inc., and the members of
Surgery
Center of Kalamazoo, LLC |
|
|
|
10.55 |
|
First Amendment to Credit Agreement
and
Consent to Acquisition dated as of May 31, 2007, by and among NovaMed,
Inc., National City Bank, as agent, and the other lenders
thereto |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
NovaMed,
Inc. |
|
|
|
Dated:
June 6, 2007 |
By: |
/s/ Scott
T.
Macomber |
|
Scott T. Macomber
Executive
Vice President and Chief Financial Officer
|
|
|
EXHIBIT
INDEX
Exhibit
Number
|
|
Title
|
|
|
|
2.1
|
|
Purchase
Agreement dated as of June 1, 2007, by and among NovaMed Acquisition
Company, Inc., and the members of Surgery Center of Kalamazoo,
LLC
|
|
|
|
10.55
|
|
First
Amendment to Credit Agreement and Consent to Acquisition dated
as of May
31, 2007, by and among NovaMed, Inc., National City Bank, as agent,
and
the other lenders thereto
|